Home/Filings/4/0001437749-24-004369
4//SEC Filing

Gruber James R. 4

Accession 0001437749-24-004369

CIK 0001710340other

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 4:21 PM ET

Size

5.2 KB

Accession

0001437749-24-004369

Insider Transaction Report

Form 4
Period: 2024-02-13
Gruber James R.
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to buy)

    2024-02-13+144,677374,763 total
    Exercise: $4.42Exp: 2034-02-12Common Stock (144,677 underlying)
Footnotes (1)
  • [F1]The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on February 13, 2028.

Issuer

Eton Pharmaceuticals, Inc.

CIK 0001710340

Entity typeother

Related Parties

1
  • filerCIK 0001923165

Filing Metadata

Form type
4
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:21 PM ET
Size
5.2 KB